Abstract
The effects of carbamazepine monotherapy were investigated in 20 female and 21 male epileptic patients to determine whether treatment would induce an increase in serum alkaline phosphatase (ALP) activity, a known effect of many anticonvulsant drugs. Serum total ALP activity was increased in nine out of the 41 patients (22%), serum bone ALP activity was increased in 10 (24%), and serum non-bone ALP activity was increased in three (7%). There was no significant difference when the mean of the patients' serum total ALP was compared with that of the controls. Twenty per cent of the patients with increased serum bone ALP had normal serum total ALP, indicating that increased serum bone isoenzyme activity may precede an increase in the total enzyme activity. This should be considered when interpreting results of increased total ALP in epileptic patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aldenhövel H. G. The influence of long-term anticonvulsant therapy with diphenylhydantoin and carbamazepine on serum gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase. Eur Arch Psychiatry Neurol Sci. 1988;237(5):312–316. doi: 10.1007/BF00450552. [DOI] [PubMed] [Google Scholar]
- Behr W., Barnert J. Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility. Clin Chem. 1986 Oct;32(10):1960–1966. [PubMed] [Google Scholar]
- Dent C. E., Richens A., Rowe D. J., Stamp T. C. Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J. 1970 Oct 10;4(5727):69–72. doi: 10.1136/bmj.4.5727.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Hare J. A., Duggan B., O'Driscoll D., Callaghan N. Biochemical evidence for osteomalacia with carbamazepine therapy. Acta Neurol Scand. 1980 Nov;62(5):282–286. doi: 10.1111/j.1600-0404.1980.tb03037.x. [DOI] [PubMed] [Google Scholar]
- Rapeport W. G. Factors influencing the relationship between carbamazepine plasma concentration and its clinical effects in patients with epilepsy. Clin Neuropharmacol. 1985;8(2):141–149. doi: 10.1097/00002826-198506000-00003. [DOI] [PubMed] [Google Scholar]
- Reynolds E. H. Chronic antiepileptic toxicity: a review. Epilepsia. 1975 Jun;16(2):319–352. doi: 10.1111/j.1528-1157.1975.tb06062.x. [DOI] [PubMed] [Google Scholar]
- Richens A., Rowe D. J. Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J. 1970 Oct 10;4(5727):73–76. doi: 10.1136/bmj.4.5727.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosalki S. B., Foo A. Y. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem. 1984 Jul;30(7):1182–1186. [PubMed] [Google Scholar]
- Siest G., Batt A. M., Galteau M. M., Weber M., Tridon P. Interférence des contraceptifs oraux et des anti-épileptiques sur les paramétres plasmatiques chez l'homme. Etude particulière des enzymes. Therapie. 1974 Nov-Dec;29(6):907–914. [PubMed] [Google Scholar]
- Skillen A. W., Pierides A. M. Serum gamma glutamyl transferase and alkaline phosphatase activities in epileptics receiving anticonvulsant therapy. Clin Chim Acta. 1976 Oct 15;72(2):245–251. doi: 10.1016/0009-8981(76)90080-2. [DOI] [PubMed] [Google Scholar]